Patents by Inventor Daniel Drolet

Daniel Drolet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250093355
    Abstract: Biomarkers, methods, devices, reagents, systems, and kits used to assess the quality of a sample collected from a subject are provided. Such biomarkers, methods, devices, reagents, systems, and kits may be useful in evaluating acceptability of sample handling and/or consistency of sample handling across a plurality of samples.
    Type: Application
    Filed: January 20, 2023
    Publication date: March 20, 2025
    Applicant: SomaLogic Operating Co., Inc.
    Inventors: David Astling, Matthew Westacott, Laura Sampson, Daniel Drolet, Dominic Zichi
  • Publication number: 20250052766
    Abstract: Biomarkers, methods, devices, reagents, systems, and kits used to assess the quality of a sample collected from a subject are provided. Such biomarkers, methods, devices, reagents, systems, and kits may be useful in evaluating compliance with fasting protocols.
    Type: Application
    Filed: April 21, 2023
    Publication date: February 13, 2025
    Applicant: SomaLogic Operating Co., Inc.
    Inventors: David Astling, Matthew Westacott, Daniel Drolet
  • Publication number: 20230167525
    Abstract: Methods for recovering gold from a refractory gold ore and concentrate are described. The method can include leaching the refractory gold ore and concentrate with the alkaline reagent under ambient or near-ambient conditions and a subsequent gold complexation. The method can optionally include separating a gold-containing leachate from a gold-unlocked solid residue obtained during the leaching step and performing a subsequent complexation on the gold-unlocked solid residue and optionally gold complexation on the gold-containing leachate. These methods can increase the gold recovery compared to conventional methods.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 1, 2023
    Applicant: COREM
    Inventors: Gnouyaro Palla ASSIMA, Benoit LEVASSEUR, Caroline OLSEN, Danielle DROLET
  • Publication number: 20220178940
    Abstract: Described herein are compositions and methods for reducing the variability of inter-sample analyte measurements from a biological matrix. In some embodiments, the present disclosure relates to methods for reducing the variability in the inter-sample levels of one or more proteins from a biological sample as measured by a proteomic assay.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 9, 2022
    Applicant: SomaLogic, Inc.
    Inventors: Daniel Drolet, David Astling, Ira von Carlowitz, Thomas Howard Hraha, Jan Hoh
  • Publication number: 20050129097
    Abstract: This invention allows the communication of mission critical data to devices that communicate within the same, or a separately connected, power distribution system. Devices operate by being connected to a power distribution system, subsystem, and or different but connected power system. Each device has a specific similar or different communication platform, architecture, protocol method and or process for performing a function and or distributing data. The invention allows all devices connected through the power system to communicate to one, some or all other devices as wanted; regardless of the type of architecture, protocol, platform, or type of power on the power system. Power systems can be connected by power or communication and can be separate. All powered devices utilizing the invention seamlessly operate, communicate and network for their specified reason(s) in their native formats without any needs of communication wiring using the power distribution system as the medium of communication.
    Type: Application
    Filed: October 14, 2004
    Publication date: June 16, 2005
    Inventors: David Strumpf, Daniel Drolet
  • Publication number: 20040053271
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
    Type: Application
    Filed: February 20, 2003
    Publication date: March 18, 2004
    Applicant: Gilead Sciences, Inc.
    Inventors: Daniel Drolet, Larry Gold
  • Patent number: 6673553
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: January 6, 2004
    Assignee: Gilead Sciences, Inc.
    Inventors: Daniel Drolet, Larry Gold
  • Patent number: 6544776
    Abstract: A diagnostic biochip comprising a solid support to which one or more specific nucleic acid ligands is attached in a spatially defined manner is provided. Each nucleic acid ligand binds specifically and avidly to a particular target molecule contained within a test mixture, such as a bodily fluid. Also provided are methods for the preparation of nucleic acid ligand biochips. Further, methods for the use of the nucleic acid ligand biochip in diagnosis of a medical condition and quantitative detection of a target molecule are provided.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: April 8, 2003
    Assignee: Somalogic, Inc.
    Inventors: Larry Gold, Daniel Drolet, Dominic A. Zichi, Sumedha Jayasena, Steve Creighton, Stanley Gill
  • Publication number: 20020137087
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
    Type: Application
    Filed: March 12, 2002
    Publication date: September 26, 2002
    Inventors: Daniel Drolet, Larry Gold
  • Patent number: 6387635
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
    Type: Grant
    Filed: August 28, 2001
    Date of Patent: May 14, 2002
    Assignee: Gilead Sciences, Inc.
    Inventors: Daniel Drolet, Larry Gold
  • Publication number: 20020055113
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
    Type: Application
    Filed: August 28, 2001
    Publication date: May 9, 2002
    Applicant: Gilead Sciences, Inc.
    Inventors: Daniel Drolet, Larry Gold
  • Patent number: 6280943
    Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
    Type: Grant
    Filed: June 17, 1999
    Date of Patent: August 28, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Daniel Drolet, Larry Gold